JIUN-KAE JACK LEE to Injections, Subcutaneous
This is a "connection" page, showing publications JIUN-KAE JACK LEE has written about Injections, Subcutaneous.
Connection Strength
0.025
-
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer. 2003 Jul; 5(1):40-5.
Score: 0.013
-
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol. 2002 Jan 15; 20(2):364-70.
Score: 0.012